83 FR 146 pgs. 36607-36608 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
Type: NOTICEVolume: 83Number: 146Pages: 36607 - 36608
Pages: 36607, 36608Docket number: [Docket Nos. FDA-2014-N-1069; FDA-2017-N-6931; FDA-2011-N-0362; FDA-2011-N-0279; FDA-2011-N-0672; FDA-2014-N-0913; FDA-2017-N-0493; and FDA-2011-N-0781]
FR document: [FR Doc. 2018-16156 Filed 7-27-18; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2014-N-1069; FDA-2017-N-6931; FDA-2011-N-0362; FDA-2011-N-0279; FDA-2011-N-0672; FDA-2014-N-0913; FDA-2017-N-0493; and FDA-2011-N-0781]
Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
[top] The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
| Title of collection | OMB control No. | Date approval expires |
|---|---|---|
| Blood Establishment Registration and Product Listing for Manufacturers of Human Blood and Blood Products and Licensed Devices; Form FDA 2830 | 0910-0052 | 6/30/2021 |
| Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components; and Requirements for Donation Testing, Donor Notification, and "Lookback" | 0910-0116 | 6/30/2021 |
| Current Good Manufacturing Practices for Finished Pharmaceuticals and Medical Gases | 0910-0139 | 6/30/2021 |
| Prescription Drug Marketing | 0910-0435 | 6/30/2021 |
| Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices | 0910-0577 | 6/30/2021 |
| Guidance FDA and Industry Procedures for Section 513(g) Requests for Information under the Federal Food, Drug, and Cosmetic Act | 0910-0705 | 6/30/2021 |
| Utilization of Adequate Provision Among Low to Non-Internet Users | 0910-0853 | 6/30/2021 |
| Record Retention Requirements for the Soy Protein/Coronary Heart Disease Health Claim | 0910-0428 | 7/31/2021 |
Dated: July 24, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-16156 Filed 7-27-18; 8:45 am]
BILLING CODE 4164-01-P